{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:48:02Z","timestamp":1777470482274,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"am","delay-in-days":708,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"University of Macau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015249","name":"University of Macau State Key Laboratory of Quality Research in Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bioorg.2024.107176","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T20:40:09Z","timestamp":1706992809000},"page":"107176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Repurposing sodium stibogluconate as an uracil DNA glycosylase inhibitor against prostate cancer using a time-resolved oligonucleotide-based drug screening platform"],"prefix":"10.1016","volume":"144","author":[{"given":"Sang-Cuo","family":"Nao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-Sheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Shiu-Hin Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yuen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Hang","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2024.107176_b0005","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cell.2019.04.009","article-title":"A high-throughput platform to identify small-molecule inhibitors of CRISPR-Cas9","volume":"177","author":"Maji","year":"2019","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107176_b0010","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1039\/B923660K","article-title":"High-throughput screening for modulators of protein\u2013protein interactions: use of photonic crystal biosensors and complementary technologies","volume":"40","author":"Heeres","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2024.107176_b0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biomaterials.2017.06.022","article-title":"High-throughput approaches for screening and analysis of cell behaviors","volume":"153","author":"Seo","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioorg.2024.107176_b0020","series-title":"High-Throughput Screening Methods for Drug Discovery","author":"Tay","year":"2022"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107176_b0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd1086","article-title":"Hit and lead generation: beyond high-throughput screening","volume":"2","author":"Bleicher","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"19","key":"10.1016\/j.bioorg.2024.107176_b0030","doi-asserted-by":"crossref","first-page":"10742","DOI":"10.1021\/acs.jmedchem.0c00523","article-title":"High-throughput screening for the discovery of enzyme inhibitors","volume":"63","author":"Lloyd","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107176_b0035","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.coph.2009.08.004","article-title":"Novel trends in high-throughput screening","volume":"9","author":"Mayr","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"issue":"21","key":"10.1016\/j.bioorg.2024.107176_b0040","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/1878-0261.13277","article-title":"Fragment-based drug discovery\u2014the importance of high-quality molecule libraries","volume":"16","author":"Bon","year":"2022","journal-title":"Mol. Oncol."},{"issue":"19","key":"10.1016\/j.bioorg.2024.107176_b0045","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.3390\/ijms21197128","article-title":"A fluorescence polarization-based high-throughput screen to identify the first small-molecule modulators of the human adenylyltransferase hype\/ficd","volume":"21","author":"Camara","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107176_b0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/acssensors.0c02046","article-title":"Time-resolved luminescent high-throughput screening platform for lysosomotropic compounds in living cells","volume":"6","author":"Wu","year":"2021","journal-title":"ACS Sensors"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107176_b0055","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1021\/acs.analchem.2c00138","article-title":"Interference reduction biosensing strategy for highly sensitive microRNA detection","volume":"94","author":"Chen","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bioorg.2024.107176_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2019.02.013","article-title":"Iridium (III)-based chemosensors for the detection of metal ions","volume":"168","author":"Ma","year":"2019","journal-title":"Methods"},{"key":"10.1016\/j.bioorg.2024.107176_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2020.128393","article-title":"G-quadruplex-based detection of glyphosate in complex biological systems by a time-resolved luminescent assay","volume":"320","author":"Chen","year":"2020","journal-title":"Sens. Actuators B"},{"key":"10.1016\/j.bioorg.2024.107176_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2020.128486","article-title":"A long-lived luminogenic iridium (III) complex for acetylacetone detection in environmental samples","volume":"321","author":"Wang","year":"2020","journal-title":"Sens. Actuators B"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107176_b0075","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1039\/C9SC05623H","article-title":"A robust photoluminescence screening assay identifies uracil-DNA glycosylase inhibitors against prostate cancer","volume":"11","author":"Li","year":"2020","journal-title":"Chem. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107176_b0080","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/AAC.27.6.916","article-title":"Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate","volume":"27","author":"Berman","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107176_b0085","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/bloodadvances.2021005367","article-title":"Sodium stibogluconate and CD47-SIRP\u03b1 blockade overcome resistance of anti-CD20\u2013opsonized B cells to neutrophil killing","volume":"6","author":"van Rees","year":"2022","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107176_b0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbrc.2003.09.055","article-title":"Inhibition of authentic hepatitis C virus replication by sodium stibogluconate","volume":"310","author":"Yeh","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"87","key":"10.1016\/j.bioorg.2024.107176_b0095","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.1039\/C6CC04938A","article-title":"Discovery of a VHL and HIF1alpha interaction inhibitor with in vivo angiogenic activity via structure-based virtual screening","volume":"52","author":"Yang","year":"2016","journal-title":"Chem. Commun. (Camb.)"},{"issue":"20","key":"10.1016\/j.bioorg.2024.107176_b0100","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1093\/nar\/gkl747","article-title":"Mimicking damaged DNA with a small molecule inhibitor of human UNG2","volume":"34","author":"Krosky","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"37","key":"10.1016\/j.bioorg.2024.107176_b0105","doi-asserted-by":"crossref","first-page":"59299","DOI":"10.18632\/oncotarget.11151","article-title":"Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damage","volume":"7","author":"Yan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2024.107176_b0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pbiomolbio.2021.02.004","article-title":"An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformation","volume":"163","author":"Nguyen","year":"2021","journal-title":"Prog. Biophys. Mol. Bio."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107176_b0115","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/cddis.2011.135","article-title":"Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair","volume":"3","author":"Bulgar","year":"2012","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107176_b0120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.bioorg.2024.107176_b0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1476-4598-5-20","article-title":"Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery","volume":"5","author":"De Angelis","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2024.107176_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108855","article-title":"Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition","volume":"114","author":"Ghosh","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107176_b0135","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1365-2133.2010.09939.x","article-title":"Low-dose 5-fluorouracil induces cell cycle G2 arrest and apoptosis in keloid fibroblasts","volume":"163","author":"Huang","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107176_b0140","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/annonc\/mdg248","article-title":"Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors","volume":"14","author":"Punt","year":"2003","journal-title":"Ann. Oncol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824000816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824000816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:56:51Z","timestamp":1758617811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824000816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"alternative-id":["S0045206824000816"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107176","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing sodium stibogluconate as an uracil DNA glycosylase inhibitor against prostate cancer using a time-resolved oligonucleotide-based drug screening platform","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107176"}}